Second cycle remission achievement with 7+3 and survival in adults with newly diagnosed acute myeloid leukemia: analysis of recent SWOG trials

Leukemia. 2019 Feb;33(2):554-558. doi: 10.1038/s41375-018-0274-y. Epub 2018 Oct 12.

Megan Othus¹, Elihu H Estey^{2

3}, Guillermo Garcia-Manero⁴, Brent L Wood⁵, Derek L Stirewalt^{2

6}, John E Godwin⁷, James K Weick⁸, Jeanne E Anderson⁹, Frederick R Appelbaum^{2

6}, Harry P Erba^{10

11}, Roland B Walter^{2

3

12}

¹ Public Health Division and SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. [email protected].
² Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
³ Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA.
⁴ Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USA.
⁵ Department of Laboratory Medicine, Division of Hematopathology, University of Washington, Seattle, WA, USA.
⁶ Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA.
⁷ Providence Cancer Center Oncology and Hematology Care Clinic, Portland, OR, USA.
⁸ VA Medical Center, North Palm Beach, FL, USA.
⁹ Katmai Oncology Group, Anchorage, AK, USA.
¹⁰ University of Alabama at Birmingham, Birmingham, AL, USA.
¹¹ Duke University, Durham, NC, USA.
¹² Department of Epidemiology, University of Washington, Seattle, WA, USA.

No abstract available

Publication types